Tower Research Capital LLC (TRC) - IN8BIO INC ownership

IN8BIO INC's ticker is and the CUSIP is 45674E109. A total of 18 filers reported holding IN8BIO INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of IN8BIO INC
ValueSharesWeighting
Q3 2023$12,203
+17.0%
11,734
+73.2%
0.00%
Q2 2023$10,432
+173766.7%
6,774
+38.7%
0.00%
Q1 2023$6
-60.0%
4,884
-26.8%
0.00%
-100.0%
Q4 2022$15
-99.6%
6,672
+266.4%
0.00%
Q3 2022$4,000
-20.0%
1,821
-16.5%
0.00%
Q2 2022$5,000
-54.5%
2,182
-35.7%
0.00%
Q1 2022$11,000
-21.4%
3,395
+6.9%
0.00%
Q4 2021$14,000
-30.0%
3,176
+9.6%
0.00%
-100.0%
Q3 2021$20,0002,8990.00%
Other shareholders
IN8BIO INC shareholders Q3 2022
NameSharesValueWeighting ↓
Voss Capital, LLC 457,876$705,1290.08%
Rock Creek Group, LP 76,314$117,5240.02%
Sigma Planning Corp 279,400$430,2760.02%
Overbrook Management Corp 33,756$51,9840.01%
Stonegate Investment Group, LLC 180,000$277,2000.01%
Westside Investment Management, Inc. 15,750$24,2550.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 49,000$75,4600.00%
Ensign Peak Advisors, Inc 470,028$723,8430.00%
GEODE CAPITAL MANAGEMENT, LLC 176,561$271,9030.00%
STATE STREET CORP 59,246$91,2390.00%
View complete list of IN8BIO INC shareholders